WHISP

Theradaptive is a clinical-stage biologics company that is privately held and focused on developing protein therapeutics for spine, orthopedics, soft tissue repair, and targeted immuno-oncology. The company's innovative platform converts recombinant proteins into material-binding variants that can be used to coat implants, devices, and injectable carriers for various medical treatments. Theradaptive's lead candidate, OsteoAdapt SP™, is currently being evaluated in a Phase I/II clinical trial for degenerative disc disease, a condition that causes spinal joint deterioration and pain. This candidate combines Theradaptive's engineered protein AMP2™ with a synthetic bone graft to address this challenging medical issue.

QuantHealth is an organization that produces software using artificial intelligence technology for drug development data. This software is utilized for conducting patient-focused medication simulations, with the aim of expediting and reducing the risks associated with drug development. By merging data from various sources within clinical and drug development fields, the company's software can forecast how patients will respond to both existing and innovative treatments. This enables pharmaceutical and biotechnology clients to conduct different versions of their clinical trials, enhancing trial design and boosting the chances of successful trials. As a result, QuantHealth aids in uncovering new clinical prospects and optimization strategies.

100 Healthy Years • Your new routine of 120+ advanced lab tests explained by the world's top doctors

Sound Health utilizes acoustic resonance to offer relief for nasal issues. Their current offering is an app which scans the face to create a map of the bone structure, along with a headband that emits personalized frequencies for a 10-minute duration. The headband is readily available and the sound levels are comparable to using earbuds. The goal is for the headband to be easily attainable without a prescription, for the convenience of all patients.

Navi Medical Technologies is a company that specializes in the development of medical devices.

Throne is a health company that focuses on individual gut wellness and hydration maintenance.

The most cutting-edge polymer-based platform of restorative cardiovascular devices was created by Xeltis. When colonised by the patient's own tissue cells, Xeltis devices naturally transform into living blood arteries or heart valves. wwwxeltiscom

Holobiome is a company that specializes in developing therapies for diseases affecting the enteric and central nervous systems. Using microbiome-based treatments, the company aims to address a range of mental health issues, as well as metabolism and immune responses. Founded in 2015, Holobiome is located in Cambridge, Massachusetts.

Firsthand knowledge of severe mental illness, in our opinion, ought to be valued more. Our founding group of healthcare experts and serial entrepreneurs have purposefully devoted their professional lives to assisting marginalised individuals with serious mental illnesses in collaboration with local nonprofits. We are actively expanding our team with like-minded business creators.

CurieDx is the image-based diagnostics using a smartphone photograph, they assist patients in recovering more quickly.

Estrigenix Therapeutics, Inc. is a non-public pharmaceutical company with a goal of creating ground-breaking medications to enhance the mental well-being of women experiencing menopause. Inaugurated in 2018, Estrigenix Therapeutics aims to enhance women's health, starting with addressing the physical and psychological impacts of menopause.

Karoo Health is a leader in tech-enabled value-based cardiovascular care solutions and aims to bring innovative, end-to-end, cardiovascular solutions to patients via partnerships with health plans and self-insured employers. As a patient-first organization, Karoo Health’s mission is to help patients lead their best lives by providing a new paradigm of better cardiology care, at lower cost, than the current system and preventing the progression of cardiovascular disease.